Zydus receives final approval from the USFDA for Acetazolamide Tablets USP, 125 mg and 250 mg

Zydus receives final approval from the USFDA for Acetazolamide Tablets USP, 125 mg and 250 mg

Acetazolamide is used to treat glaucoma, a condition in which increased pressure in the eye can lead to gradual loss of vision.

FPJ Web DeskUpdated: Thursday, April 06, 2023, 04:44 PM IST
article-image
Zydus receives final approval from the USFDA for Acetazolamide Tablets USP, 125 mg and 250 mg | Image: Zydus (Representative)

Zydus Lifesciences Limited (including its subsidiaries/affiliates, hereafter referred to as “Zydus”) has received final approval from the United States Food and Drug Administration (USFDA) to manufacture and market Acetazolamide Tablets USP, 125 mg and 250 mg (USRLD: Diamox Tablets, 125 mg and 250 mg).

Acetazolamide is used to treat glaucoma, a condition in which increased pressure in the eye can lead to gradual loss of vision. Acetazolamide decreases the pressure in the eye. Acetazolamide is also used to reduce the severity and duration of symptoms (upset stomach, headache, shortness of breath, dizziness, drowsiness, and fatigue) of altitude (mountain) sickness. The drug is used with other medicines to reduce edema (excess fluid retention) and to help control seizures in certain types of epilepsy. The product will be manufactured at the group’s formulation manufacturing facility in Baddi, Himachal Pradesh (India).

Acetazolamide Tablets USP, 125 mg and 250 mg had annual sales of USD 16 mn in the United States (IQVIA MAT Dec. 2022).

The group now has 358 approvals and has so far filed over 440* ANDAs since the commencement of the filing process in FY 2003-04.

(To receive our E-paper on WhatsApp daily, please click here.  To receive it on Telegram, please click here. We permit sharing of the paper's PDF on WhatsApp and other social media platforms.)

RECENT STORIES

Mumbai: Tightening Noose on Online Real Money Gaming Co - DGGI Sends Notices for GST Dues of...

Mumbai: Tightening Noose on Online Real Money Gaming Co - DGGI Sends Notices for GST Dues of...

Blue Star Acquires 4.9 Crore Equity Shares of Blue Star Climatech through QIP

Blue Star Acquires 4.9 Crore Equity Shares of Blue Star Climatech through QIP

India One Of Most Competitive Markets; IndiGo Seeks To Become More Global: Pieter Elbers

India One Of Most Competitive Markets; IndiGo Seeks To Become More Global: Pieter Elbers

CM Dhami-Led Uttarakhand Govt Signs MoU Of Investments Worth ₹2,000 Crore With Poma Group

CM Dhami-Led Uttarakhand Govt Signs MoU Of Investments Worth ₹2,000 Crore With Poma Group

Tax Department Notifies 'Angel Tax' Rules For Valuing Investments In Startups

Tax Department Notifies 'Angel Tax' Rules For Valuing Investments In Startups